Corrigendum to Commission Regulation (EC) No 508/1999 of 4 March 1999 amending Annexes I to IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin ( OJ L 60, 9.3.1999 )

Published date19 November 2009
Official Gazette PublicationOfficial Journal of the European Union, L 304, 19 November 2009
L_2009304EN.01002401.xml
19.11.2009 EN Official Journal of the European Union L 304/24

Corrigendum to Commission Regulation (EC) No 508/1999 of 4 March 1999 amending Annexes I to IV of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin

( Official Journal of the European Communities L 60 of 9 March 1999 )

On page 38, Annex II, category 2 ‘Organic compounds’, under the entry for the pharmacologically active substance Rifaximin, third column ‘Other provisions’:

for:

‘For intramammary use, except if the udder may be used as food for human consumption’,

read:

‘For intramammary use, except if the udder may be used as food for human consumption, and intrauterine use only’.


To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT